Cargando…

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis

PURPOSE: Wild-type transthyretin-related amyloidosis cardiomyopathy (ATTRwt-CM) is an increasingly recognized cause of heart failure especially in elderly patients. The purpose of the present study was to determine retrospectively whether the quantitative indices of (99m)Tc-pyrophosphate (PYP) SPECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Kouji, Shiraishi, Shinya, Tsuda, Noriko, Sakamoto, Fumi, Oda, Seitarou, Takashio, Seiji, Tsujita, Kenichi, Hirai, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068718/
https://www.ncbi.nlm.nih.gov/pubmed/34973114
http://dx.doi.org/10.1007/s11604-021-01221-6
_version_ 1784700278361030656
author Ogasawara, Kouji
Shiraishi, Shinya
Tsuda, Noriko
Sakamoto, Fumi
Oda, Seitarou
Takashio, Seiji
Tsujita, Kenichi
Hirai, Toshinori
author_facet Ogasawara, Kouji
Shiraishi, Shinya
Tsuda, Noriko
Sakamoto, Fumi
Oda, Seitarou
Takashio, Seiji
Tsujita, Kenichi
Hirai, Toshinori
author_sort Ogasawara, Kouji
collection PubMed
description PURPOSE: Wild-type transthyretin-related amyloidosis cardiomyopathy (ATTRwt-CM) is an increasingly recognized cause of heart failure especially in elderly patients. The purpose of the present study was to determine retrospectively whether the quantitative indices of (99m)Tc-pyrophosphate (PYP) SPECT/CT help to predict the prognosis of ATTRwt-CM patients when compared with other clinical parameters. MATERIALS AND METHODS: Sixty-eight patients with biopsy-proven ATTRwt-CM who underwent PYP SPECT/CT were enrolled. Baseline clinical characteristics, echocardiographic parameters, and qualitative and/or quantitative indices of planar and SPECT/CT imaging in PYP scintigraphy for each patient were included. For quantitative analysis of SPECT/CT, the accumulation ratio of PYP in the septum, posterior, anterior, lateral, and apex walls to the cavity pool was calculated as the septal wall-to-cavity ratio (Se/C), lateral wall-to-cavity ratio (La/C), anterior wall-to-cavity ratio (An/C), inferior wall-to-cavity ratio (In/C), and apical wall-to-cavity ratio (Ap/C), respectively. Endpoints for prognostic accuracy evaluation were cardiac death or hospitalization due to heart failure. Event-free survival rate was evaluated through Cox proportional hazards regression analysis, providing estimated hazard ratios (HRs) with 95% confidence intervals (CIs) and Kaplan–Meier curves. RESULTS: High-sensitivity cardiac troponin T (hs-cTnT), La/C, age, interventricular septal thickness in diastole, and E/e′ ratio in the septal wall were significantly associated with event-free survival (P < 0.05). For a multivariable Cox proportional hazards analysis, hs-cTnT (HR 1.153; 95% CI 1.034–1.286; P < 0.01), La/C (HR 2.091; 95% CI 1.012–4.322; P = 0.046), and age (HR 1.116; 95% CI 1.007–1.238; P = 0.037) were significant independent prognostic factors. CONCLUSION: This study indicated that the quantitative indices of PYP SPECT/CT can help to predict the prognosis of ATTRwt-CM patients.
format Online
Article
Text
id pubmed-9068718
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-90687182022-05-07 Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis Ogasawara, Kouji Shiraishi, Shinya Tsuda, Noriko Sakamoto, Fumi Oda, Seitarou Takashio, Seiji Tsujita, Kenichi Hirai, Toshinori Jpn J Radiol Original Article PURPOSE: Wild-type transthyretin-related amyloidosis cardiomyopathy (ATTRwt-CM) is an increasingly recognized cause of heart failure especially in elderly patients. The purpose of the present study was to determine retrospectively whether the quantitative indices of (99m)Tc-pyrophosphate (PYP) SPECT/CT help to predict the prognosis of ATTRwt-CM patients when compared with other clinical parameters. MATERIALS AND METHODS: Sixty-eight patients with biopsy-proven ATTRwt-CM who underwent PYP SPECT/CT were enrolled. Baseline clinical characteristics, echocardiographic parameters, and qualitative and/or quantitative indices of planar and SPECT/CT imaging in PYP scintigraphy for each patient were included. For quantitative analysis of SPECT/CT, the accumulation ratio of PYP in the septum, posterior, anterior, lateral, and apex walls to the cavity pool was calculated as the septal wall-to-cavity ratio (Se/C), lateral wall-to-cavity ratio (La/C), anterior wall-to-cavity ratio (An/C), inferior wall-to-cavity ratio (In/C), and apical wall-to-cavity ratio (Ap/C), respectively. Endpoints for prognostic accuracy evaluation were cardiac death or hospitalization due to heart failure. Event-free survival rate was evaluated through Cox proportional hazards regression analysis, providing estimated hazard ratios (HRs) with 95% confidence intervals (CIs) and Kaplan–Meier curves. RESULTS: High-sensitivity cardiac troponin T (hs-cTnT), La/C, age, interventricular septal thickness in diastole, and E/e′ ratio in the septal wall were significantly associated with event-free survival (P < 0.05). For a multivariable Cox proportional hazards analysis, hs-cTnT (HR 1.153; 95% CI 1.034–1.286; P < 0.01), La/C (HR 2.091; 95% CI 1.012–4.322; P = 0.046), and age (HR 1.116; 95% CI 1.007–1.238; P = 0.037) were significant independent prognostic factors. CONCLUSION: This study indicated that the quantitative indices of PYP SPECT/CT can help to predict the prognosis of ATTRwt-CM patients. Springer Nature Singapore 2022-01-01 2022 /pmc/articles/PMC9068718/ /pubmed/34973114 http://dx.doi.org/10.1007/s11604-021-01221-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ogasawara, Kouji
Shiraishi, Shinya
Tsuda, Noriko
Sakamoto, Fumi
Oda, Seitarou
Takashio, Seiji
Tsujita, Kenichi
Hirai, Toshinori
Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
title Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
title_full Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
title_fullStr Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
title_full_unstemmed Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
title_short Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
title_sort usefulness of quantitative (99m)tc-pyrophosphate spect/ct for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068718/
https://www.ncbi.nlm.nih.gov/pubmed/34973114
http://dx.doi.org/10.1007/s11604-021-01221-6
work_keys_str_mv AT ogasawarakouji usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT shiraishishinya usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT tsudanoriko usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT sakamotofumi usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT odaseitarou usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT takashioseiji usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT tsujitakenichi usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis
AT hiraitoshinori usefulnessofquantitative99mtcpyrophosphatespectctforpredictingtheprognosisofpatientswithwildtypetransthyretincardiacamyloidosis